(83) validated that anti-PD-1 antibody (4H2) could decrease Treg infiltration in subcutaneously implanted models of murine osteosarcoma cell line LM8, and finally, tumor volume decreased in size and overall survival was prolonged. Here, PDCD1 is linked to osteosarcoma.